Company News for Nov 29, 2019

Zacks Equity Research Published on November 29, 2019

Shares of Diplomat Pharmacy, Inc. gained 12.1% after the company posted revenues of $1.3 billion for third-quarter 2019, beating the Zacks Consensus Estimate by 11.8%.
Shares of Box, Inc. (BOX - Free Report) rose 11.5% after the company reported total revenues of $177.16 million in Q3, which surpassed the Zacks Consensus Estimate of $174.5 million.
Shares of Central Garden & Pet Company (CENT - Free Report) declined 17.5% after the company reported fourth-quarter fiscal 2019 earnings of 4 cents a share, which lagged the Zacks Consensus Estimate of 17 cents.
Shares of Evolent Health, Inc. (EVH - Free Report) lost 27.3% after Passport Health, which is owned by Evolent Health, couldn’t secure prominent Medicaid contracts in Kentucky.

Zacks Names "Single Best Pick to Double"

From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.

It’s a little-known chemical company that’s up 65% over last year, yet still dirt cheap. With unrelenting demand, soaring 2022 earnings estimates, and $1.5 billion for repurchasing shares, retail investors could jump in at any time.

This company could rival or surpass other recent Zacks’ Stocks Set to Double like Boston Beer Company which shot up +143.0% in little more than 9 months and NVIDIA which boomed +175.9% in one year.